Rushmie Nofsinger
Investor Relations Contact chez SCHOLAR ROCK HOLDING CORPORATION
Profil
Rushmie Nofsinger is currently the Head-Investors & Media at Scholar Rock Holding Corp.
She previously worked as a Media Contact at AMAG Pharmaceuticals, Inc.
Postes actifs de Rushmie Nofsinger
| Sociétés | Poste | Début |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Investor Relations Contact | 01/12/2021 |
Anciens postes connus de Rushmie Nofsinger
| Sociétés | Poste | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Public Communications Contact | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
